Education

Relfydess recieves for glabellar lines in China

Pharmaceutical company Galderma has announced that China’s National Medical Products Administration (NPA) has approved Relfydess (relabotulinumtoxinA) for the temporary improvement of moderate-to-severe glabellar lines in adults. The approval is supported

Read More »

A Summary of the Latest Clinical Studies

The latest research highlights from Professor Sebastian Cotofana Key Takeaways Title: Understanding Facial Ageing Through Facial Biomechanics: A Clinically Applicable Guide for Improved Outcomes Authors: Lysander Freytag et al. Published:

Read More »